Eliana De Gregorio

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Low Density Lipoprotein

Staphylococcus Aureus

Biofilm Formation

Top Venues

Antibiotics (Basel, Switzerland)

Pathogens (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Stabile, Anna Esposito, Vita Dora Iula, Annalisa Guaragna, Eliana De Gregorio
PYED-1 Overcomes Colistin Resistance in Acinetobacter baumannii . Pathogens (Basel, Switzerland) 12 (11) (2023)
Antonella Migliaccio, Maria Stabile, Maria Bagattini, Maria Triassi, Rita Berisio, Eliana De Gregorio, Raffaele Zarrilli
Resveratrol Reverts Tolerance and Restores Susceptibility to Chlorhexidine and Benzalkonium in Gram-Negative Bacteria, Gram-Positive Bacteria and Yeasts. Antibiotics (Basel, Switzerland) 11 (7) (2022)
Anna Esposito, Antonella Migliaccio, Vita Dora Iula, Raffaele Zarrilli, Annalisa Guaragna, Eliana De Gregorio
The Glucocorticoid PYED-1 Disrupts Mature Biofilms of Candida spp. and Inhibits Hyphal Development in Candida albicans. Antibiotics (Basel, Switzerland) 10 (11) (2021)
Pierpaolo Di Nocera, Eliana De Gregorio
Growth by Insertion: The Family of Bacterial DDxP Proteins. International journal of molecular sciences 21 (23) (2020)
Anna Esposito, Daniele D'Alonzo, Stefano D'Errico, Eliana De Gregorio, Annalisa Guaragna
Toward the Identification of Novel Antimicrobial Agents: One-Pot Synthesis of Lipophilic Conjugates of N-Alkyl d- and l-Iminosugars. Marine drugs 18 (11) (2020)
Eliana De Gregorio, Anna Esposito, Adriana Vollaro, Maria De Fenza, Daniele D'Alonzo, Antonella Migliaccio, Vita Dora Iula, Raffaele Zarrilli, Annalisa Guaragna
N-Nonyloxypentyl-l-Deoxynojirimycin Inhibits Growth, Biofilm Formation and Virulence Factors Expression of Staphylococcus aureus. Antibiotics (Basel, Switzerland) 9 (6) (2020)
Anna Esposito, Eliana De Gregorio, Maria De Fenza, Daniele D'Alonzo, Anil Satawani, Annalisa Guaragna
Expeditious synthesis and preliminary antimicrobial activity of deflazacort and its precursors. RSC advances 9 (37) (2019)